| [1] |
Pinte L, Balaban D V, Baicus C, et al. Non-alcoholic fatty pancreas disease-practices for clinicians[J]. Rom J Intern Med, 2019, 57(3): 209-219.
|
| [2] |
Schaefer J H. The normal weight of the pancreas in the adult human being: A biometric study[J]. The Anatomical Record, 1926, 32(2): 119-132.
|
| [3] |
Ogilvie RF. The islands of langerhans in 19 cases of obesity[J]. The Journal of Pathology and Bacteriology, 1933, 37: 473-481.
|
| [4] |
Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(3): 153-168.
|
| [5] |
SILVA L, FERNANDES MSS, LIMA EA, et al. Fatty Pancreas: Disease or Finding?[J]. Clinics(Sao Paulo), 2021, 76: e2439.
|
| [6] |
Caldart F, De Pretis N, Luchini C, et al. Pancreatic steatosis and metabolic pancreatic disease: a new entity?[J]. Intern Emerg Med, 2023, 18(8): 2199-2208.
|
| [7] |
Habas E, Farfar K, Habas E, et al. Extended Review and Updates of Nonalcoholic Fatty Pancreas Disease[J]. Saudi J Med Med Sci, 2024, 12(4): 284-291.
|
| [8] |
Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study[J]. Diabetes Metab Res Rev, 2010, 26(3): 200-205.
|
| [9] |
Yamazaki H, Tauchi S, Kimachi M, et al. Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study[J]. J Gastroenterol, 2018, 53(7): 873-882.
|
| [10] |
Ke P, Sc C, C L, et al. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition[J]. Obesity Research, 2008, 16(3): 522-530.
|
| [11] |
Singh Rg, Yoon Hd, Wu LM, et al. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression[J]. Metabolism, 2017, 69: 1-13.
|
| [12] |
Fujii M, Ohno Y, Yamada M, et al. Impact of fatty pancreas and lifestyle on the development of subclinical chronic pancreatitis in healthy people undergoing a medical checkup[J]. Environ Health Prev Med, 2019, 24(1): 10.
|
| [13] |
Kim HJ, Byun JH, Park SH, et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI[J]. AJR Am J Roentgenol, 2007, 188(2): 429-432.
|
| [14] |
Hong CW, Fazeli Dehkordy S, Hooker JC, et al. Fat Quantification in the Abdomen[J]. Top Magn Reson Imaging, 2017, 26(6): 221-227.
|
| [15] |
Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss[J]. Int J Obes(Lond), 2015, 39(3): 480-487.
|
| [16] |
Kim J, Albakheet SS, Han K, et al. Quantitative MRI Assessment of Pancreatic Steatosis Using Proton Density Fat Fraction in Pediatric Obesity[J]. Korean J Radiol, 2021, 22(11): 1886-1893.
|
| [17] |
Siddiqui N, Vendrami C L, Chatterjee A, et al. Advanced MR Imaging Techniques for Pancreas Imaging[J]. Magn Reson Imaging Clin N Am, 2018, 26(3): 323-344.
|
| [18] |
Sezgin O, Yaras S, Ozdogan O. Pancreatic Steatosis Is Associated with Both Metabolic Syndrome and Pancreatic Stiffness Detected by Ultrasound Elastography[J]. Dig Dis Sci, 2022, 67(1): 293-304.
|
| [19] |
Hirooka Y, Kuwahara T, Irisawa A, et al. JSUM ultrasound elastography practice guidelines: pancreas[J]. J Med Ultrason(2001), 2015, 42(2): 151-174.
|
| [20] |
Pang C, Dong P, Yang J, et al. Non-alcoholic fatty pancreas disease: an updated review[J]. J Pancreatol, 2024, 7(3): 212-221.
|
| [21] |
Marti-Aguado D, Ten-Esteve A, Baracaldo-Silva C M, et al. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease[J]. Front Endocrinol(Lausanne), 2023, 14: 1213441.
|
| [22] |
Dong X, Zhu Q, Yuan C, et al. Associations of Intrapancreatic Fat Deposition With Incident Diseases of the Exocrine and Endocrine Pancreas: A UK Biobank Prospective Cohort Study[J]. Am J Gastroenterol, 2024, 119(6): 1158-1166.
|
| [23] |
Mederos M A, Reber H A, Girgis M D. Acute Pancreatitis: A Review[J]. JAMA, 2021, 325(4): 382-390.
|
| [24] |
Matta B, Gougol A, Gao X, et al. Worldwide Variations in Demographics, Management, and Outcomes of Acute Pancreatitis[J]. Clin Gastroenterol Hepatol, 2020, 18(7): 1567-1575 e1562.
|
| [25] |
Karim M M, Ur Rehman A, Majeed M A, et al. Pancreatic steatosis-a new modifiable high-risk factor for post-ERCP pancreatitis: yet much to explore[J]. Gastrointest Endosc, 2024, 100(3): 579-580.
|
| [26] |
KO J, Skudder-Hill L, Priya S, et al. Associations between Intra-Pancreatic Fat Deposition, Pancreas Size, and Pancreatic Enzymes in Health and after an Attack of Acute Pancreatitis[J]. Obes Facts, 2022, 15(1): 70-82.
|
| [27] |
Yan C, Bao J, Jin J. Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease[J]. J Transl Med, 2024, 22(1): 179.
|
| [28] |
Singh R G, Cervantes A, Kim J U, et al. Intrapancreatic fat deposition and visceral fat volume are associated with the presence of diabetes after acute pancreatitis[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(6): G806-G815.
|
| [29] |
Stefanaki C, Paltoglou G, Mastorakos G, et al. Chronic Stress and Steatosis of Muscles, Bones, Liver, and Pancreas: A Review[J]. Horm Res Paediatr, 2023, 96(1): 66-73.
|
| [30] |
Adiamah A, Psaltis E, Crook M, et al. A systematic review of the epidemiology, pathophysiology and current management of hyperlipidaemic pancreatitis[J]. Clin Nutr, 2018, 37(6 Pt A): 1810-1822.
|
| [31] |
Pagkali A, Makris A, Brofidi K, et al. Pathophysiological Mechanisms and Clinical Associations of Non-Alcoholic Fatty Pancreas Disease[J]. Diabetes Metab Syndr Obes, 2024, 17: 283-294.
|
| [32] |
Navina S, Acharya C, Delany J P, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity[J]. Sci Transl Med, 2011, 3(107): 107ra110.
|
| [33] |
Durgampudi C, Noel P, Patel K, et al. Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation[J]. Am J Pathol, 2014, 184(6): 1773-1784.
|
| [34] |
Lilly A C, Astsaturov I, Golemis E A. Intrapancreatic fat, pancreatitis, and pancreatic cancer[J]. Cell Mol Life Sci, 2023, 80(8): 206.
|
| [35] |
Duarte-Rojo A, Sosa-Lozano L A, Saul A, et al. Methods for measuring abdominal obesity in the prediction of severe acute pancreatitis, and their correlation with abdominal fat areas assessed by computed tomography[J]. Aliment Pharmacol Ther, 2010, 32(2): 244-253.
|
| [36] |
Park J, Chang JH, Park SH, et al. Interleukin-6 is associated with obesity, central fat distribution, and disease severity in patients with acute pancreatitis[J]. Pancreatology, 2015, 15(1): 59-63.
|
| [37] |
Kuan LL, Dennison A R, Garcea G. Association of visceral adipose tissue on the incidence and severity of acute pancreatitis: A systematic review[J]. Pancreatology, 2020, 20(6): 1056-1061.
|
| [38] |
Patel K, Trivedi RN, Durgampudi C, et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation[J]. Am J Pathol, 2015, 185(3): 808-819.
|
| [39] |
Vancsa S, Nemeth D, Hegyi P, et al. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis[J]. J Clin Med, 2020, 9(9).
|
| [40] |
Mikolasevic I, Orlic L, Poropat G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis[J]. Eur J Intern Med, 2017, 38: 73-78.
|
| [41] |
Lin T Y, Zhang Y F, Wang Y, et al. Nonalcoholic fatty liver disease aggravates acute pancreatitis through bacterial translocation and cholesterol metabolic dysregulation in the liver and pancreas in mice[J]. Hepatobiliary Pancreat Dis Int, 2023, 22(5): 504-511.
|
| [42] |
Ren D, Li Y, Zhang G, et al. Lipid metabolic profiling and diagnostic model development for hyperlipidemic acute pancreatitis[J]. Front Physiol, 2024, 15: 1457349.
|
| [43] |
Otsuka N, Shimizu K, Taniai M, et al. Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer[J]. Front Physiol, 2023, 14: 1243983.
|
| [44] |
Truong E, Pandol S, Jeon C. Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer[J]. EBioMedicine, 2022, 79: 103996.
|
| [45] |
Chalasani N, Younossi Z, Lavine J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 67(1): 328-357.
|
| [46] |
Petrov MS. The Pharmacological Landscape for Fatty Change of the Pancreas[J]. Drugs, 2024, 84(4): 375-384.
|
| [47] |
Jia DM, Fukumitsu KI, Tabaru A, et al. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats[J]. Am J Physiol Regul Integr Comp Physiol, 2001, 280(5): R1332-1340.
|
| [48] |
Souza-Mello V, Gregorio BM, Relvas-Lucas B, et al. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice[J]. Pancreas, 2011, 40(5): 715-722.
|
| [49] |
Chen ZY, Liu SN, Li CN, et al. Atorvastatin helps preserve pancreatic beta cell function in obese C57BL/6 J mice and the effect is related to increased pancreas proliferation and amelioration of endoplasmic-reticulum stress[J]. Lipids Health Dis, 2014, 13: 98.
|
| [50] |
Sandoval DA, Patti ME. Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia[J]. Nat Rev Endocrinol, 2023, 19(3): 164-176.
|
| [51] |
Ji Y, Lee H, Kaura S, et al. Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms[J]. Biomolecules, 2021, 11(11): 1582.
|
| [52] |
Hui Scn, Wong Skh, Ai Q, et al. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI[J]. Eur Radiol, 2019, 29(2): 849-856.
|